President Donald Trump recently signed an executive order aimed at lowering prescription drug prices. However, experts told KFF Health News the policy’s rollout reveals a slow, conditional path that ...

As part of a broader resurgence in pharmaceutical pricing reform and manufacturing policies in 2025, President Donald Trump ...

Experts said Trump’s action could lower the cost of prescription drugs, but they cautioned it's far from an immediate fix.

Rep. Ro Khanna — one of most liberal members of the House — has introduced a bill that puts President Donald Trump's latest ...

The executive order that President Donald Trump signed to lower drug prices could come under legal challenges by the drug industry.

A study by the Rand Corp., a nonpartisan research organization, found that, across all drugs, U.S. prices were 2.78 times as ...

The Most Favored Nation order is unlikely to deliver broad, sustained savings without triggering legal challenges, ...

The president announced last week that his administration would be instituting a “most favored nation” policy that would peg ...

The inflated prices in the United States fuel global innovation while foreign health systems get a free ride.” ...

One can desire lower-cost access to drugs while being troubled by President Trump's executive order (EO) last week. Critics ...

Is there anyone who thinks prescription drug prices in America are about right? President Trump has elevated an issue ...

President Trump's executive order aims to slash prescription drug prices by up to 80% by targeting pharmacy benefit managers, ...